Differential 1 -adrenoceptor labeling by [ 3 H]prazosin and [ 3 H]tamsulosin

By Michel M.C.   Goepel M.  

European Journal of Pharmacology, Vol. 342, Iss. 1, 1998-01 ,pp. : 85-92

Elsevier

Access to resources Recommend Favorite

Pharmacological blockade of brain 1 -adrenoceptors as measured by ex vivo [ 3 H]prazosin binding is correlated with behavioral immobility

By Stone E.A.   Rosengarten H.   Lin Y.   Quartermain D.  

European Journal of Pharmacology, Vol. 420, Iss. 2, 2001-05 ,pp. : 97-102

Elsevier

Access to resources Recommend Favorite

Binding and functional characterization of 1 -adrenoceptor subtypes in the rat prostate

By Hiraoka Y.   Ohmura T.   Oshita M.   Watanabe Y.   Morikawa K.   Nagata O.   Kato H.   Taniguchi T.   Muramatsu I.  

European Journal of Pharmacology, Vol. 366, Iss. 1, 1999-01 ,pp. : 119-126

Elsevier

Access to resources Recommend Favorite

2 -Adrenoceptor subtypes in the human brain: a pharmacological delineation of [ 3 H]RX-821002 binding to membranes and tissue sections

By Grijalba B.   Callado L.F.   Meana J.J.   Garcia-Sevilla J.A.   Pazos A.  

European Journal of Pharmacology, Vol. 310, Iss. 1, 1996-08 ,pp. : 83-93

Elsevier

Access to resources Recommend Favorite

[ 3 H]R-Terazosin binds selectively to 1 -adrenoceptors over 2 -adrenoceptors - comparison with racemic [ 3 H]terazosin and [ 3 H]prazosin

By Ireland L.M.   Cain J.C.   Rotert G.   Thomas S.   Shoghi S.   Hancock A.A.   Kerwin J.F.  

European Journal of Pharmacology, Vol. 327, Iss. 1, 1997-05 ,pp. : 79-86

Elsevier

Access to resources Recommend Favorite